81 related articles for article (PubMed ID: 26512585)
1. Association Between Heme Oxygenase-1 Promoter Polymorphisms and the Development of Albuminuria in Type 2 Diabetes: A Case-Control Study.
Lee EY; Lee YH; Kim SH; Jung KS; Kwon O; Kim BS; Nam CM; Park CS; Lee BW; Kang ES; Cha BS; Lee HC
Medicine (Baltimore); 2015 Oct; 94(43):e1825. PubMed ID: 26512585
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.
Yamada N; Yamaya M; Okinaga S; Nakayama K; Sekizawa K; Shibahara S; Sasaki H
Am J Hum Genet; 2000 Jan; 66(1):187-95. PubMed ID: 10631150
[TBL] [Abstract][Full Text] [Related]
3. Heme Oxygenase-1 Gene (GT)n Polymorphism Linked to Deep White Matter Hyperintensities, Not Periventricular Hyperintensities.
Chen J; Li J; Wang X; Fu X; Ke J; Li J; Wen J; Cheng K; Li S; Shi Z
J Am Heart Assoc; 2024 Jun; 13(11):e033981. PubMed ID: 38818928
[TBL] [Abstract][Full Text] [Related]
4. The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality.
Chin HJ; Cho HJ; Lee TW; Na KY; Yoon HJ; Chae DW; Kim S; Jeon US; Do JY; Park JW; Yoon KW; Shin YT; Lee KW; Na KR; Cha DR; Kang YS;
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S30-7. PubMed ID: 19194559
[TBL] [Abstract][Full Text] [Related]
5. Association of lung function decline with the heme oxygenase-1 gene promoter microsatellite polymorphism in a general population sample. Results from the European Community Respiratory Health Survey (ECRHS), France.
Guénégou A; Leynaert B; Bénessiano J; Pin I; Demoly P; Neukirch F; Boczkowski J; Aubier M
J Med Genet; 2006 Aug; 43(8):e43. PubMed ID: 16882737
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of heme-oxygenase 1 (HO-1) may impact on acute kidney injury, bronchopulmonary dysplasia, and mortality in premature infants.
Askenazi DJ; Halloran B; Patil N; Keeling S; Saeidi B; Koralkar R; Ambalavanan N
Pediatr Res; 2015 Jun; 77(6):793-8. PubMed ID: 25751573
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic Associations With the HMOX1 GT(n) Repeat in European Populations.
Hamilton F; Mitchell R; Ghazal P; Timpson N
Am J Epidemiol; 2024 May; 193(5):718-726. PubMed ID: 37414746
[TBL] [Abstract][Full Text] [Related]
8. Morphometric analysis of human gingival elastic fibres degradation by human leukocyte elastase protective effect of avocado and soybean unsaponifiables (ASU).
Kut C; Assoumou A; Dridi M; Bonnefoix M; Gogly B; Pellat B; Guillou GB; Godeau G
Pathol Biol (Paris); 1998 Sep; 46(7):571-6. PubMed ID: 9842576
[TBL] [Abstract][Full Text] [Related]
9. [Chemical constituents of Eclipta alba (L.) Hassk].
Zhang M; Chen Y
Zhongguo Zhong Yao Za Zhi; 1996 Aug; 21(8):480-1, 510. PubMed ID: 9642409
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Transcriptomic Background of Oxidative Stress and Antioxidative Therapies in Late Complications of Type 2 Diabetes Mellitus: A Systematic Review.
Tonin G; Dolžan V; Klen J
Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539811
[TBL] [Abstract][Full Text] [Related]
11. Association of Low Serum Bilirubin Concentrations and Promoter Variations in the
Jirásková A; Škrha J; Vítek L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445792
[TBL] [Abstract][Full Text] [Related]
12. Association between HO‑1 gene promoter polymorphisms and diseases (Review).
Ma LL; Sun L; Wang YX; Sun BH; Li YF; Jin YL
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34841438
[TBL] [Abstract][Full Text] [Related]
13. Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.
McClung JA; Levy L; Garcia V; Stec DE; Peterson SJ; Abraham NG
Pharmacol Ther; 2022 Mar; 231():107975. PubMed ID: 34499923
[TBL] [Abstract][Full Text] [Related]
14. Heme Oxygenase 1: A Defensive Mediator in Kidney Diseases.
Grunenwald A; Roumenina LT; Frimat M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670516
[TBL] [Abstract][Full Text] [Related]
15. Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications.
Singh D; Wasan H; Reeta KH
Free Radic Biol Med; 2020 Dec; 161():263-271. PubMed ID: 33091573
[TBL] [Abstract][Full Text] [Related]
16. Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes.
Lee I; Lee HH; Cho Y; Choi YJ; Huh BW; Lee BW; Kang ES; Park SW; Cha BS; Lee EJ; Lee YH; Huh KB
J Lipid Atheroscler; 2020 Jan; 9(1):195-204. PubMed ID: 32821731
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the heme oxygenase-1 and bone morphogenetic protein receptor type 1b genes and estimated glomerular filtration rate in Brazilian sickle cell anemia patients.
Chinedu O; Tonassé WV; Albuquerque DM; Domingos IF; Araújo ADS; Bezerra MAC; Sonati MF; Santos MNND
Hematol Transfus Cell Ther; 2021; 43(2):165-170. PubMed ID: 32461055
[TBL] [Abstract][Full Text] [Related]
18. A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.
He D; Huang JH; Zhang ZY; Du Q; Peng WJ; Yu R; Zhang SF; Zhang SH; Qin YH
Drug Des Devel Ther; 2019; 13():3989-4005. PubMed ID: 31819371
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Association Between Heme Oxygenase-1 Promoter Polymorphisms and the Development of Albuminuria in Type 2 Diabetes: A Case-Control Study: Erratum.
Medicine (Baltimore); 2016 Jan; 95(1):e955b. PubMed ID: 31265555
[TBL] [Abstract][Full Text] [Related]
20. Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients.
Tsai MT; Tarng DC
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
